|
|
Volumn 22, Issue 4, 2015, Pages 269-277
|
|
Pharmacokinetics and safety of vilazodone in hepatic impairment
a
|
|
Author keywords
antidepressants; hepatic impairment; pharmacokinetics; phase 1 study; vilazodone
|
|
Indexed keywords
VILAZODONE;
SEROTONIN UPTAKE INHIBITOR;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD SAMPLING;
BODY MASS;
CLINICAL ARTICLE;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DIARRHEA;
DIZZINESS;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG SAFETY;
ELECTROCARDIOGRAM;
FEMALE;
HEADACHE;
HEPATIC IMPAIRMENT;
HUMAN;
LIQUID CHROMATOGRAPHY;
LIVER DISEASE;
LIVER FUNCTION;
MAJOR DEPRESSION;
MALE;
MAXIMUM PLASMA CONCENTRATION;
MEDICAL HISTORY;
MIDDLE AGED;
MODERATE HEPATIC IMPAIRMENT;
MORNING DOSAGE;
NAUSEA;
PHASE 1 CLINICAL TRIAL;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SEVERE HEPATIC IMPAIRMENT;
SINGLE DRUG DOSE;
TANDEM MASS SPECTROMETRY;
TIME TO MAXIMUM PLASMA CONCENTRATION;
VOMITING;
ADOLESCENT;
DEPRESSIVE DISORDER, MAJOR;
DRUG EFFECTS;
LIVER;
LIVER DISEASES;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AGED;
AREA UNDER CURVE;
DEPRESSIVE DISORDER, MAJOR;
FEMALE;
HUMANS;
LIVER;
LIVER DISEASES;
MALE;
MIDDLE AGED;
SEROTONIN UPTAKE INHIBITORS;
VILAZODONE HYDROCHLORIDE;
YOUNG ADULT;
|
|
EID: 84937641937
PISSN: 10752765
EISSN: 15363686
Source Type: Journal
DOI: 10.1097/MJT.0000000000000173 Document Type: Article |
|
Times cited : (7)
|
|
References (8)
|
